Skip to main content
    I

    Innospec Inc (IOSP)

    Official site

    BASIC MATERIALS • SPECIALTY CHEMICALS • NASDAQ

    $79.17
    -1.22 (-1.52%)

    Market Cap: $1.98B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Innospec Inc (IOSP) Financials: Revenue, Profit and Cash Flow

    Updated Nov 3, 2026. Financial statements from company filings, amounts in US dollars.

    Innospec reported revenue of $1.78B for the fiscal year ended Dec 31, 2025, down 3.7% from the year before. That year, net income was $116.60M with a net margin of 6.6%, operating cash flow was $138.30M and free cash flow was $62.80M. The quarter ended Sep 30, 2026 had revenue of $473.60M and net income of $31.60M.

    Revenue and Margins

    The operating margin was 7.3% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $883.40M, a compound annual rate of 8.1%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$1.78B-3.7%27.7%7.3%6.6%
    Dec 2024$1.85B-5.3%29.4%9.6%1.9%
    Dec 2023$1.95B-0.8%30.3%8.3%7.1%
    Dec 2022$1.96B+32.4%29.9%9.5%6.8%
    Dec 2021$1.48B+24.3%29.3%8.9%6.3%
    Dec 2020$1.19B-21.2%28.7%2.8%2.4%
    Dec 2019$1.51B+2.5%30.8%9.9%7.4%
    Dec 2018$1.48B+13.0%29.5%9.0%5.8%
    Dec 2017$1.31B+47.9%30.9%9.6%4.7%
    Dec 2016$883.40MN/A37.6%11.1%9.2%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, net income rose 227.5% from the year before. In the quarter ended Sep 2026, net income rose 148.8% from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$1.78B$1.85B$1.95B$1.96B$1.48B$1.19B$1.51B$1.48B$1.31B$883.40M
    Cost of revenue$1.29B$1.30B$1.36B$1.38B$1.05B$850.40M$1.05B$1.04B$903.50M$551.10M
    Gross profit$492.40M$542.90M$591.10M$586.70M$434.90M$342.70M$466.20M$435.00M$403.30M$332.30M
    Research and development$51.00M$56.50M$49.00M$38.70M$37.40M$30.90M$35.40M$33.40M$31.40M$25.40M
    Operating income$129.50M$177.90M$161.60M$187.30M$132.10M$33.70M$149.90M$133.50M$125.00M$98.20M
    Net income$116.60M$35.60M$139.10M$133.00M$93.10M$28.70M$112.20M$85.00M$61.80M$81.30M
    EBITDA$172.50MN/A$211.40M$225.80M$178.60M$87.50M$202.80M$188.10M$186.70M$144.40M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$473.60M$491.40M$453.20M$455.60M$441.90M$439.70M$440.80M$466.80M$443.40M$435.00M$500.20M$494.70M
    Gross profit$129.10M$138.30M$123.50M$127.40M$116.70M$123.20M$125.10M$136.20M$124.10M$126.90M$155.70M$155.70M
    Operating income$41.70M$39.70M$36.50M$46.80M$5.90M$34.30M$42.50M$41.10M$45.60M$40.70M$50.50M$44.50M
    Net income$31.60M$31.20M$30.80M$47.40M$12.70M$23.90M$33.60M-$70.40M$33.40M$31.20M$41.40M$37.80M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded short-term debt of $7.00M by $285.50M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$1.83B$1.73B$1.71B$1.60B$1.57B$1.40B$1.47B$1.47B$1.41B$1.18B
    Current assets$1.00B$956.60M$885.70M$872.60M$728.10M$566.20M$630.30M$663.90M$0$441.10M
    Cash and equivalents$292.50M$289.20M$203.70M$147.10M$141.80M$105.30M$75.70M$123.10M$90.20M$101.90M
    Total liabilities$499.50M$518.60M$557.80M$563.30M$537.90M$452.50M$549.90M$647.90M$48.60M$527.60M
    Short-term debt$7.00M$0$13.60M$13.90M$12.50M$11.80M$1.00M$23.20M$18.50M$11.90M
    Long-term debtN/AN/AN/AN/AN/AN/A$58.60M$186.20M$202.60M$258.50M
    Shareholder equity$1.33B$1.21B$1.15B$1.04B$1.03B$944.40M$918.50M$825.00M$794.30M$653.50M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$1.86B$1.85B$1.82B$1.83B$1.80B$1.81B$1.77B$1.73B$1.80B$1.70B$1.73B$1.71B
    Total liabilities$476.30M$495.20M$467.60M$499.50M$496.50M$504.60M$508.90M$518.60M$550.10M$504.40M$546.60M$557.80M
    Cash and equivalents$251.90M$250.20M$289.10M$292.50M$270.80M$266.60M$299.80M$289.20M$303.80M$240.20M$270.10M$203.70M
    Shareholder equity$1.37B$1.34B$1.34B$1.33B$1.30B$1.30B$1.26B$1.21B$1.24B$1.19B$1.18B$1.15B
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 45.4% of operating cash flow. Dividends and share repurchases together came to 105.6% of it.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow$138.30M$184.50M$207.30M$81.70M$93.20M$145.90M$161.60M$104.90M$82.70M$105.50M
    Capital expenditures$75.50M$62.30M$77.20M$42.30M$39.10M$29.70M$31.00M$30.10M$28.00M$16.50M
    Free cash flow$62.80M$122.20M$130.10M$39.40M$54.10M$116.20M$130.60M$74.80M$54.70M$89.00M
    Dividends paid$42.40M$38.80M$35.10M$31.70M$28.80M$25.60M$25.00M$21.70M$18.60M$59.90M
    Share repurchases$23.90M$700.00K$1.10M$5.90M$800.00K$2.10M$2.40M$1.40M$1.10M$8.40M
    Investing cash flow-$75.10M-$62.00M-$111.80M-$42.10M-$36.20M-$29.70M-$31.00M-$35.50M-$29.60M-$209.10M
    Financing cash flow-$63.90M-$35.30M-$39.00M-$33.70M-$20.00M-$86.80M-$177.90M-$36.20M-$66.40M$69.50M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$17.40M$7.20M$17.60M$61.40M$39.10M$10.50M$28.30M$25.70M$73.50M$4.70M$80.60M$72.40M
    Capital expenditures$15.80M$17.70M$14.00M$21.20M$22.10M$16.60M$15.60M$20.80M$11.80M$15.30M$14.40M$21.20M
    Free cash flow$1.60M-$10.50M$3.60M$40.20M$17.00M-$6.10M$12.70M$4.90M$61.70M-$10.60M$66.20M$51.20M
    Last 12 quarters

    Frequently Asked Questions About IOSP

    What is Innospec's annual revenue?

    Innospec reported revenue of $1.78B for the fiscal year ended Dec 31, 2025.

    How fast is Innospec's revenue growing?

    Revenue was down 3.7% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -3.3%.

    Is Innospec profitable?

    Yes. Innospec reported net income of $116.60M for the fiscal year ended Dec 31, 2025, with a net margin of 6.6%.

    How much free cash flow does IOSP generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $138.30M minus capital expenditures of $75.50M produced free cash flow of $62.80M.

    How much debt does Innospec have?

    The balance sheet dated Dec 31, 2025 reported short-term debt of $7.00M and cash and equivalents of $292.50M.